<div id="readability-page-1"><p>Acropolis Investment Management LLC grew its holdings in shares of  UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 49.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor  owned 15,371 shares of the healthcare conglomerate's stock after buying an additional 5,077 shares during the quarter. Acropolis Investment Management LLC's holdings in UnitedHealth Group were worth $5,308,000 at the end of the most recent reporting period.</p><div><p><span></span><span>Get <strong>UnitedHealth Group</strong> alerts:</span></p></div><ul><li>The Top 3 Investment Themes That Will Dominate 2026</li></ul><p>Several other institutional investors have also modified their holdings of UNH. Threadgill Financial LLC bought a new position in  UnitedHealth Group during the 3rd quarter valued at about $249,000.  1620 Investment Advisors Inc. grew its stake in shares of  UnitedHealth Group by 140.8% during the third quarter. 1620 Investment Advisors Inc. now owns 578 shares of the healthcare conglomerate's stock valued at $200,000 after buying an additional 338 shares during the last quarter.  Assenagon Asset Management S.A. boosted its holdings in  UnitedHealth Group by 521.3% during the 3rd quarter. Assenagon Asset Management S.A. now owns 1,232,251 shares of the healthcare conglomerate's stock valued at $425,496,000 after acquiring an additional 1,033,912 shares during the period.  Cullen Investment Group LTD. lifted its position in shares of  UnitedHealth Group by 18.6% during the third quarter. Cullen Investment Group LTD. now owns 18,242 shares of the healthcare conglomerate's stock worth $6,569,000 after purchasing an additional 2,866 shares during the last quarter.  Finally, Quintet Private Bank Europe S.A. grew its holdings in shares of  UnitedHealth Group by 2.2% in the third quarter. Quintet Private Bank Europe S.A. now owns 85,197 shares of the healthcare conglomerate's stock worth $29,419,000 after purchasing an additional 1,833 shares during the last quarter. 87.86% of the stock is owned by institutional investors. </p><h2>Analyst Upgrades and Downgrades</h2><p>Several research firms have commented on UNH. Weiss Ratings upgraded UnitedHealth Group from a &#34;sell (d+)&#34; rating to a &#34;hold (c-)&#34; rating in a report on Friday, October 24th. Zacks Research upgraded UnitedHealth Group from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a report on Monday, October 6th. Truist Financial lifted their target price on UnitedHealth Group from $310.00 to $365.00 and gave the company a &#34;buy&#34; rating in a research note on Tuesday, September 9th. KeyCorp increased their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an &#34;overweight&#34; rating in a research report on Wednesday, October 8th. Finally, Jefferies Financial Group boosted their price objective on shares of UnitedHealth Group from $317.00 to $409.00 and gave the stock a &#34;buy&#34; rating in a research note on Friday, October 17th. Seventeen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned  a Sell rating to the company's stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of &#34;Hold&#34; and an average price target of $385.54.</p><ul><li>5 Healthcare Names to Watch as Sector Rotation Is in Full Swing</li></ul><p><b>Read Our Latest Analysis on UnitedHealth Group</b></p><h2>UnitedHealth Group Stock Down 0.8%</h2><p>NYSE:UNH opened at $331.60 on Thursday. The company's 50 day moving average is $338.14 and its two-hundred day moving average is $317.84. The company has a market cap of $300.38 billion, a PE ratio of 17.31, a P/E/G ratio of 2.18 and a beta of 0.43. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $606.36. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71. </p><ul><li>Snowflake Stock Is on Fire—It’s Still Not Too Late to Buy</li></ul><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. During the same period in the prior year, the firm earned $7.15 EPS. The firm's revenue was up 12.2% on a year-over-year basis.  Analysts anticipate that  UnitedHealth Group Incorporated will post 29.54 EPS for the current year. </p><h2>UnitedHealth Group Dividend Announcement</h2><p>The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend was Monday, December 8th. UnitedHealth Group's dividend payout ratio  is 46.14%. </p><h2>UnitedHealth Group Profile</h2> (Free Report)<p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than UnitedHealth Group</li><li>Stock Average Calculator      </li><li>Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport</li><li>How to Plot Fibonacci Price Inflection Levels </li><li>Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock</li><li>Profitably Trade Stocks at 52-Week Highs</li><li>Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2><p>Before you consider UnitedHealth Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p><p>While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Acropolis Investment Management LLC increased its stake in UnitedHealth Group by 49.3% in Q3, owning 15,371 shares valued at $5.3 million. Other institutional investors also adjusted their holdings. UnitedHealth's stock has mixed analyst ratings, with a current average rating of 'Hold' and a price target of $385.54. The company reported Q3 earnings of $2.92 per share, slightly above estimates, with revenue up 12.2% year-over-year.</p>

Acropolis Investment Management LLC Boosts Stock Position in UnitedHealth Group Incorporated $UNH